Journal List > Kosin Med J > v.28(2) > 1056998

Jang, Lee, Han, Park, Kang, Kim, and Suh: Clinical Features and Histological Findings of 17 Patients with Chronic Actinic Dermatitis

Abstract

Objectives

This study was designed to evaluate the clinical, histological and immunohistochemical findings and treatment of chronic actinic dermatitis in Korean patients.

Methods

Seventeen Korean patients with chronic actinic dermatitis were enrolled for this study. The clinical and histological findings and the results of phototest were reviewed with medical records, clinical photographs and pathologic slides. We also reviewed the effectiveness of the treatments in all patients with chronic actinic dermatitis.

Results

In all patients with chronic actinic dermatitis, pruritus was severe, and the patients present in the early stages with erythemas on the face, neck and the back of the hands. As the eruption progresses, it became lichenified and scaly plaques and papules developed. The face, upper extremity and neck were most commonly affected. The most common abnormal results of the phototests were decreased MED-UVB alone. In 8 patients with actinic reticuloid, histopathologic findings showed irregular acanthosis, parakeratosis, spongiosis, atypical hyperchromatic cells with cerebriform nuclei, epidermotropism, Pautrier-like microabscess, deep perivascular lymphocytic infiltrates, vertically-streaked collagen in the papillary dermis, stellate and multinucleated fibroblasts. Treatment includes topical tacrolimus and corticosteroid, oral corticosteroid, azathioprine and cyclosporine.

Conclusions

Our study showed classic clinical and histological findings. The most common abnormal results of the phototests were decreased MED-UVB alone. Topical steroid, tacrolimus and systemic cyclosporine, azathioprine are effective in treating chronic actinic dermatitis.

REFERENCES

1.Hawk JL., Lim HW. Chronic actinic dermatitis. Lim HW, Hönigsmann H, Hawk JL, editors. editors.Photodermatology. 1st ed.New York: Informa Healthcare;2007. p. 169–83.
crossref
2.Hawk JL. Chronic actinic dermatitis. Photodermatol Pho-toimmunol Photomed. 2004. 20:312–4.
crossref
3.Uetsu N., Okamoto H., Fujii K., Doi R., Horio T. Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol. 2002. 47:881–4.
crossref
4.Ma Y., Lu Z. Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study. J Dermatolog Treat. 2010. 21:171–7.
crossref
5.Cho HJ., Hann SK., Shin HK., Park YK., Lee KH. Effects and significance of cyclosporine therapy in chronic actinic dermatitis. Korean J Dermatol. 1997. 35:458–64.
6.Dawe RS., Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther. 2003. 16:45–51.
crossref
7.Stinco G., Codutti R., Frattasio A., De Francesco V., Patrone P. Chronic actinic dermatitis treated with cyclosporine-A. Eur J Dermatol. 2002. 12:455–7.
8.Kim JK., Li Chen., Kim TH. Three cases of chronic actinic dermatitis treated with systemic PUVA therapy. Ann Dermatol. 1997. 9:197–200.
crossref
9.Beach RA., Pratt MD. Chronic actinic dermatitis: clinical cases, diagnostic workup, and therapeutic management. J Cutan Med Surg. 2009. 13:121–8.
crossref
10.Bakels V., van Oostveen JW., Preesman AH., Meijer CJ., Willemze R. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. J Clin Pathol. 1998. 51:154–8.
crossref
11.Heller P., Wieczorek R., Waldo E., Meola T., Buchness MR., Soter NA, et al. Chronic actinic dermatitis: An immunohistochemical study of its T-cell antigenic profile, with comparison to cutaneous T-cell lymphoma. Am J Dermatopathol. 1994. 16:510–6.
12.Toonstra J., van der Putte SC., van Wichen DF., van Weelden H., Henquet CJ., van Vloten W. Actinic reticuloid: immunohistochemical analysis of the cutaneous infiltrate in 13 patients. Br J Dermatol. 1989. 120:779–86.
crossref
13.Kim KH., Nam JT., Joh GY. A case of chronic actinic dermatitis. Korean J Dermatol. 1992. 30:906–12.
14.Lim HW., Morison WL., Kamide R., Buchness MR., Harris R., Soter NA. Chronic actinic dermatitis: An analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol. 1994. 130:1284–9.
crossref
15.Won CH., Youn JI. Clinical study of 12 cases with chronic actinic dermatitis. Korean J Dermatol. 2007. 45:1144–8.
16.Sim SJ., Eim JJ., Song KH., Joh GY., Kim KH. Results of photopatch and patch tests in 35 Korean patients with chronic actinic dermatitis and clinical importance of these findings. Korean J Dermatol. 2004. 42:976–82.
17.Yap LM., Foley P., Crouch R., Baker C. Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology clinic. Australas J Dermatol. 2003. 44:256–62.
crossref
18.Tan AW., Lim KS., Theng C., Chong WS. Chronic actinic dermatitis in Asian skin: a Singaporean experience. Photodermatol Photoimmunol Photomed. 2011. 27:172–5.
crossref
19.Jeon YS., Suh KS., Kim ST. A comparison of minimal erythema dose and minimal melanogenic dose induced by ultraviolet A-1, broad band ultraviolet A, narrow band ultraviolet B, and broad band ultraviolet B. Korean J Dermatol. 2005. 43:442–9.
20.Hawk JL., Magnus IA. Chronic actinic dermatitis: an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol. 1979. 101:24.
21.Norris PG., Hawk JL. Chronic actinic dermatitis: a unifying concept. Arch Dermatol. 1990. 126:376–8.
crossref
22.Ive FA., Magnus IA., Warin RP., Jones EW. "Actinic reticuloid"; a chronic dermatosis associated with severe photosensitivity and the histological resemblance to lymphoma. Br J Dermatol. 1969. 81:469–85.
23.Zak-Prelich M., Schwartz RA. Actinic reticuloid. Int J Dermatol. 1999. 38:335–42.
crossref
24.Chew AL., Bashir SJ., Hawk JL., Palmer R., White IR., McFadden JP. Contact and photocontact sensitization in chronic actinic dermatitis: a changing picture. Contact Dermatitis. 2010. 62:42–6.
crossref
25.Que SK., Brauer JA., Soter NA., Cohen DE. Chronic actinic dermatitis: an analysis at a single institution over 25 years. Dermatitis. 2011. 22:147–54.
crossref
26.Kim YC., Song WK. A comparison of UVB - induced minimal erythema dose (MED)s to the skin of the back and extremities in young adult Koreans. Korean J Dermatol. 1998. 36:261–5.
27.De Silva BD., McLaren K., Kavanagh GM. Photosensitive mycosis fungoides or actinic reticuloid? Br J Dermatol. 2000. 142:1221–7.
crossref
28.Cerroni L., Gatter K., Kerl H. Skin lymphoma: the illustrated guide. 3rd ed.Oxford: Wiley-Black well;2009. p. 11–56.
29.Goodlad J., Calonje E. Cutaneous lymphoproliferative diseases and related disorders. Calonje E, Brenn T, Lazar A, McKee PH, editors. editors.McKee's pathology of the skin with clinical correlations. 4th ed.Philadelphia: Elsevier;2011. p. 1311–420.
30.Weedon D. Weedon's skin pathology. 3rd ed.London: Churchill Livingstone Elsevier;2010. p. 525–40.

Fig. 1.
(A) Irregular acanthosis, and lymphocytic infiltration in the papillary dermis and reticular dermis (H&E, x 40), (B) Epidermotropism, irregular acanthosis and a perivascular infiltrate of the papillary dermis (H&E, x 100) (Case 16).
kmj-28-145f1.tif
Fig. 2.
Immunohistochemical studies showed that CD4 positive T cells (A) and CD8 positive T cells (B) were in the epidermis and dermis (x 100). CD8 positive T cells predominated in the epidermis (B) compared to CD4 positive T cells (A). (Case 6).
kmj-28-145f2.tif
Fig. 3.
Immunohistochemical studies showed that CD4 positive T cells (A) and CD8 positive T cells (B) were in the epidermis and dermis (x 100). CD8 positive T cells predominated in the epidermis (B) compared to CD4 positive T cells (A). (Case 6).
kmj-28-145f3.tif
Fig. 4.
Immunohistochemical studies showed that CD4 positive T cells (A) and CD8 positive T cells (B) were in the epidermis and dermis (x 100). CD8 positive T cells predominated in the epidermis (B) compared to CD4 positive T cells (A). (Case 6).
kmj-28-145f4.tif
Table 1.
Summary of clinical characteristics in patients with chronic actinic dermatitis
Case Sex Age (yr) Fitzpatrick skin type Duration Site
Occupation
Face Neck Upper extremities
1 M 27 III 10 years ○ (forearm) Student
2 M 74 III 2 years ○ (hand) Unknown
3 M 64 IV 2 years Farmer
4 M 54 III 1 year Office worker
5 M 57 IV 6 months ○ (hand) Office worker
6 F 46 III 1 year House wife
7 M 67 IV 10 years ○ (hand) Farmer
8 M 50 IV 2 years Office worker
9 F 54 III 7 months House wife
10 M 56 IV 8 months Office worker
11 M 61 III 4 years Office worker
12 M 72 III 1 year Farmer
13 M 61 III 1 year Unknown
14 M 69 IV 10 years Laborer
15 M 60 IV 4 years Unknown
16 M 67 IV 4 years ○ (forearm) Farmer
17 M 60 IV 1 year Unknown
Table 2.
Results of phototests in patients with chronic actinic dermatitis
Case Minimal Erythema Dose
Visible light
UVA (J/cm2) UVB (mJ/cm2)
1 >40 35 NR
2 35 >40 NR
3 >40 30 NR
4 >40 35 NR
5 >40 30 NR
6 35 25 NR
7 30 35 NR
8 30 25 NR
9 >40 35 NR
10 >40 30 NR
11 >40 35 NR
12 35 >40 NR
13 30 >40 NR
14 35 >40 NR
15 35 >40 NR
16 >40 30 NR
17 35 30 NR

NR, non reactive

Table 3.
Results of photopatch tests in patients with chronic actinic dermatitis
Case 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Photo
patch test
- DN DN - - - DN - DN - DN - DN DN DN DN DN

DN, data not shown.

Table 4.
Summary of treatment in patients with chronic actinic dermatitis
Number Treatment Clinical response of skin lesions and pruritus
1 Oral azathioprine, oral steroid Partial improvement
2 Oral azathioprine, oral steroid, topical steroid Partial improvement
3 Oral azathioprine, oral steroid, topical tacrolimus Complete improvement
4 Topical steroid Partial improvement
5 Topical steroid Partial improvement
6 Oral azathioprine, oral steroid, topical tacrolimus Partial improvement
7 Oral cyclosprine, topical steroid Complete improvement
8 Oral cyclosprine, topical steroid Partial improvement
9 Oral cyclosprine, topical tacrolimus Partial improvement
10 Oral cyclosprine, topical steroid Complete improvement
11 Oral cyclosprine, topical steroid Complete improvement
12 Oral cyclosprine, topical steroid Complete improvement
13 Topical steroid Partial improvement
14 Oral cyclosprine, topical tacrolimus Complete improvement
15 Oral cyclosprine, topical steroid Partial improvement
16 Oral cyclosprine, topical steroid Partial improvement
17 Oral cyclosprine Partial improvement
TOOLS
Similar articles